Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
3
×
san francisco blog main
san francisco top stories
cancer
cancer drugs
clinical trials
hepatitis b
new york blog main
new york top stories
the column group
abbvie
aligos therapeutics
allergan aesthetics
alzheimer's disease
amgen
astrazeneca
athira pharma
attralus
baker brothers life sciences
benzodiazepine
biontech
biotech ipos
blackstone group
blepharitis
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
cavion
cephalgia
chiesi farmaceutici
cholestatic liver diseases
chronic hepatitis b virus
click therapeutics
colorectal cancer
What
way
3
×
medicines
research
acquisitions
biggest
bio
biotechs
build
buy
cancer
cancer’s
central
ceo
cns
company’s
daniel
debut
disease
disorder
drug
drugs
dyne’s
emerged
frontiers
gilead
ipo
ipos
kept
known
leads
maps
microbiome
moves
nervous
openly
o’day
parlance
pharmaceutical
pipeline
play
Language
unset
3
×
Current search:
unset
×
way
×
" national top stories "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers